Gain Therapeutics (GANX) Non-Current Assets (2020 - 2026)
Gain Therapeutics (GANX) recorded Non-Current Assets of $452,191 in Q2 2026, down 14.2% from $527,277 a year earlier and down 12.5% from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Gain Therapeutics reported Non-Current Assets of $581,837, up 11.6% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $521,406 in FY2024 (-37.2%), $830,463 in FY2023 (-72.4%), $3.01 million in FY2022 (+138.2%) and $1.26 million in FY2021 (+104.9%).
- The Q2 2026 figure is the lowest quarterly Non-Current Assets in data going back to Q4 2020.
- On a year-over-year basis, Non-Current Assets rose in two of the last eight quarters, with an average decline of 17.3%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 495.1% in Q2 2022, against a decline of 84.3% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $516,696 (Q1 2026), $581,837 (Q4 2025) and $454,412 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.83 Bn | 1,107.41 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 618.88 Bn | 537.41 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 502.93 Bn | 476.04 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 369.61 Bn | 323.99 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.70 Bn | 262.69 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.59 Bn | 192.99 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.60 Bn | 165.79 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.23 Bn | 116.88 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Gain Therapeutics | 51.45 Mn | -7.83 Mn | - | 452,191.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 452,191.00 |
| Mar 31, 2026 | 516,696.00 |
| Dec 31, 2025 | 581,837.00 |
| Sep 30, 2025 | 454,412.00 |
| Jun 30, 2025 | 527,277.00 |
| Mar 31, 2025 | 472,647.00 |
| Dec 31, 2024 | 521,406.00 |
| Sep 30, 2024 | 624,324.00 |
| Jun 30, 2024 | 657,308.00 |
| Mar 31, 2024 | 714,661.00 |
| Dec 31, 2023 | 830,463.00 |
| Sep 30, 2023 | 855,891.00 |
| Jun 30, 2023 | 952,426.00 |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 3.01 Mn |
| Sep 30, 2022 | 3.98 Mn |
| Jun 30, 2022 | 6.06 Mn |
| Mar 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 1.01 Mn |
API Access
Gain Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();